Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2511246rdf:typepubmed:Citationlld:pubmed
pubmed-article:2511246lifeskim:mentionsumls-concept:C0926407lld:lifeskim
pubmed-article:2511246lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:2511246lifeskim:mentionsumls-concept:C0125259lld:lifeskim
pubmed-article:2511246lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:2511246lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:2511246lifeskim:mentionsumls-concept:C0337112lld:lifeskim
pubmed-article:2511246pubmed:issue11lld:pubmed
pubmed-article:2511246pubmed:dateCreated1990-1-5lld:pubmed
pubmed-article:2511246pubmed:abstractTextThe generation of lamin B autoantibodies was examined in a patient with SLE. Lamin B autoantibodies in this individual's serum were almost entirely IgG1 lambda at the onset of the autoimmune response. There was no evidence of IgM to IgG class switching, and no apparent diversification of the autoantibody response over the next 2 yr. The kappa/lambda L chain ratio of the lamin B autoantibodies was 0.13 by ELISA, with a kappa/lambda ratio of 0.70 for the patient's total IgG. In contrast, anti-histone autoantibodies in the patient's serum contained primarily kappa L chain. The kappa/lambda L chain ratios of lamin B autoantibodies from sera of four other patients with SLE were also consistent with restricted heterogeneity of lamin autoantibodies. In two, lambda L chain predominated, and in two others, the lamin B autoantibodies contained predominantly kappa L chains. The restricted heterogeneity of lamin B autoantibodies could be related to targeting of a single immunodominant autoepitope, to the existence of a particular L chain gene or genes that preferentially undergo somatic mutation, leading to the production of lamin B reactive clones, or to a combination of both mechanisms.lld:pubmed
pubmed-article:2511246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:languageenglld:pubmed
pubmed-article:2511246pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2511246pubmed:statusMEDLINElld:pubmed
pubmed-article:2511246pubmed:monthDeclld:pubmed
pubmed-article:2511246pubmed:issn0022-1767lld:pubmed
pubmed-article:2511246pubmed:authorpubmed-author:AliS ASAlld:pubmed
pubmed-article:2511246pubmed:authorpubmed-author:ReevesW HWHlld:pubmed
pubmed-article:2511246pubmed:issnTypePrintlld:pubmed
pubmed-article:2511246pubmed:day1lld:pubmed
pubmed-article:2511246pubmed:volume143lld:pubmed
pubmed-article:2511246pubmed:ownerNLMlld:pubmed
pubmed-article:2511246pubmed:authorsCompleteYlld:pubmed
pubmed-article:2511246pubmed:pagination3614-8lld:pubmed
pubmed-article:2511246pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:meshHeadingpubmed-meshheading:2511246-...lld:pubmed
pubmed-article:2511246pubmed:year1989lld:pubmed
pubmed-article:2511246pubmed:articleTitlePreferential use of lambda L chain in lamin B autoantibodies.lld:pubmed
pubmed-article:2511246pubmed:affiliationLaboratory of Cell Biology, Rockefeller University, New York 10021.lld:pubmed
pubmed-article:2511246pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2511246pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2511246pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed